Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Med University with MD. In 1985, maintained his PhD at I.M. Sechenov Moscow Medical Academy. In 2001, maintained his Doctor Degree at the National Inst of Immunology. From 1985 through 1987, worked as a Post Doc Research Associate, Inst of Med Enzymology, USSR Academy of Medical Sciences. From 1987 through 1989, was a Senior Res Associate, Koltzov Inst of Developmental Biology, USSR Academy of Sciences. From 1989 through 1995, was being a Head of the Lab of Clin Immunology and Immunobiotechnology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004, was being a Chairman of the Dept for Clin Immunology, Moscow Clinical Research Institute (MONIKI). In 1993-1996, was an Executice Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov is: Chair, Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI), and Director, Center for Personalized Medicine, Sechenov University, Russia An author of more than 500 publications including 10 patents and more than 10 monographs, hand-books and textbooks published in Russia and USA. Dr Suchkov is a member of the: â— New York Academy of Sciences, USA â— American Chemical Society (ACS), USA; â— American Heart Association (AHA), USA; â— EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brussels, EU; â— ARVO (American Association for Research in Vision and Ophthalmology); â— ISER (International Society for Eye Research); Dr Suchkov is Secretary General, United Cultural Convention (UCC), Cambridge, UK. A member of the Editorial Boards of Open J of Immunology, EPMA J, Int J of Nanomedicine and Nanosurgery, SciFed Nanotech Research Letters, American J. of Cardiovascular Research, Transla-tional Medicine, Jacobs J of Biomarkers, J Applied Pharmaceutical Research (JOAPR), and â€œPer-sonalized Medicine Universe.